Status: Recruiting
A Phase 1 Study of GZC8072 Tablets Following a Single Dose in Healthy Study Participants and Multiple Doses in Obese/Overweight Study Participants
This trial is conducted in China. This study plans to include 2 parts, i.e., a single-dose study and a multiple-dose study: The single-dose study will be conducted in healthy adult participants to evaluate the safety, tolerability, and pharmacokinetic profile of single doses of GZC8072 Tablets; The multiple-dose study will be conducted in obese or overweight study participants to evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic profiles of multiple doses of GZC8072 Tablets.
Participants needed: 126
Trial details
Phase: Phase 1Age: 18-55Biological sex: AllType: InterventionalSponsor: Gan & Lee Pharmaceuticals.Updated: Sep 30, 2026Locations: 1
Eligibility criteria
Provide written informed consent, fully understand the purpose and stipulated pr... [+7]
History of allergic diathesis, or allergic diseases such as bronchial asthma, ur... [+46]